Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Stroke and Vascular Neurology|May 6, 2021
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trialYongjun Wang, Claiborne Johnston, Philip M Bath, et al.Journal of Epidemiology and Community Health|September 8, 2021
Association between annual household income and adverse outcomes in patients who had ischaemic strokeYuhan Zang, Zhengbao Zhu, Mengyao Shi, et al.Molecular Therapy. Advances|June 15, 2026
Seroprevalence of anti-AAV neutralizing antibodiesin healthy and retinitis pigmentosa cohorts: A multi-province study in ChinaJingxiao Du, Huixun Jia, Xuewei Xie, et al.International Journal of Stroke : Official Journal of the International Stroke Society|May 10, 2025
Decade trends in risk factors, treatments, and prognosis of minor ischemic stroke and TIA in ChinaQianmei Jiang, Mengxing Wang, Tao Liu, et al.Stroke|January 13, 2026
Lp-PLA2 Activity and Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic AttackJinxi Lin, Hongyu Zhou, Yubo Wang, et al.Stroke|June 12, 2026
Tirofiban for Reduction of TEAR: A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled TrialXinyan Hu, Qianmei Jiang, Ning Wang, et al.Medical Image Analysis|June 25, 2026
DGCD-3D: Difference-guided conditional diffusion model for low-field 3D MRI enhancement to assist stroke assessmentHao Li, Ziyang Liu, Yu Zhou, et al.Annals of Neurology|December 26, 2022
Genotype-Guided Dual Antiplatelet Use for Transient Ischemic Attack and Minor Stroke by Imaging Status: Subgroup Analysis of the CHANCE-2 TrialJing Jing, Xuewei Xie, S Claiborne Johnston, et al.Hypertension (Dallas, Tex. : 1979)|December 5, 2025
Antihypertensive Treatments After Acute Ischemic Stroke: to Continue or Not?Chongke Zhong, Ming Wang, Dacheng Liu, et al.Stroke|August 7, 2023
Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 TrialXuewei Xie, Jing Jing, Xia Meng, et al.Pageof 8